Clinical Trials Browser

Not yet recruiting × lenvatinib × Breast × Clear all

NCT06849492 2025-02-27

SHIFT-001

Phase 2 Not yet recruiting

Advanced Triple Negative Breast Cancer

NCT06140576 2023-11-20

The Efficacy and Safety of Lenvatinib Combined With Sindilimab and Nab-paclitaxel in the First-line Treatment for Recurrent and Metastatic Triple Negative Breast Cancer: a Phase Ib/IIa Clinical Trial.

Phase 1/2 Not yet recruiting

Breast Neoplasms